Real-world evaluation of compliance and preference in Alzheimer's disease treatment
Pai, Ming-Chyi; Aref, Hany; Bassil, Nazem; Kandiah, Nagaendran; Lee, Jae-Hong; Srinivasan, A V; diTommaso, Shelley; Yuksel, Ozgur;
Abstract
Rivastigmine transdermal patch has shown higher caregiver satisfaction and greater preference than oral formulation in patients with Alzheimer's disease. However, there is limited literature available related to caregiver preference or treatment compliance in real-world clinical settings. To date, no such data are available from Asia and the Middle East, which account for a sizeable proportion of patients with Alzheimer's disease. The objective of this study was to evaluate treatment preference and compliance with oral and transdermal medications in daily clinical practice in an ethnically diverse patient population from Asia and the Middle East with mild-to-moderate Alzheimer's disease.
Other data
Title | Real-world evaluation of compliance and preference in Alzheimer's disease treatment | Authors | Pai, Ming-Chyi ; Aref, Hany ; Bassil, Nazem ; Kandiah, Nagaendran ; Lee, Jae-Hong ; Srinivasan, A V ; diTommaso, Shelley ; Yuksel, Ozgur | Issue Date | 2015 | Journal | Clinical interventions in aging | DOI | 1779-87 10 1178-1998 10.2147/CIA.S85319 |
PubMed ID | 26622172 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.